Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
NCT00410306
·
clinicaltrials.gov ↗
COMPLETED
Status
1493
Enrollment
INDUSTRY
Sponsor class
Conditions
Male
Hypogonadism
Interventions
DRUG:
Testosterone Undecanoate (Nebido, BAY86-5037)
Sponsor
Bayer